Addiction & Impulse Control Researchers are investigating GLP-1 therapy for its potential in addressing substance use disorders
Improvements in the understanding of the complex pathogenesis of T2D has resulted in the development of several new-generation glucose-lowering agents with complementary mechanisms of action, which have expanded treatment options and management strategies for patients with T2D
These are also referred to as melanotan I and melanotan II, or MT-1 and MT-2, respectively
I thought that I was somewhat knowledgeable in health and nutrition
Recently, three new axes have been identified, emphasizing the role of the kidney in this picture (22): The ACE2/ANG(1-7)/Mas receptor pathway (23, 24): Ang-(1-7) binds to the G protein-coupled receptor Mas, which is expressed in renal proximal tubular cells, afferent arterioles, cardiac myocytes, and neuronal cells